Get the Stockscreener App
18.02
5.01%
0.84
Caredx Inc stock is traded at $18.02, with a volume of 687.55K.
It is up +5.01% in the last 24 hours and up +20.51% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.18
Open:
$17.28
24h Volume:
687.55K
Relative Volume:
0.54
Market Cap:
$927.33M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-6.6989
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
+16.31%
1M Performance:
+20.51%
6M Performance:
+6.43%
1Y Performance:
-22.01%
1-Day Range:
$17.04
$18.20
1-Week Range:
$15.22
$18.20
52-Week Range:
$10.96
$26.37
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
18.03 | 883.61M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
586.96 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.83 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
748.73 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
152.93 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
227.66 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Will CareDx Inc stock benefit from green energy trendsJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
CareDx at Stephens Conference: Growth and Strategic Focus By Investing.com - Investing.com Canada
Why CareDx Inc (1K9) stock gets analyst attentionRecession Risk & AI Based Trade Execution Alerts - newser.com
Why CareDx Inc stock is recommended by analystsTake Profit & Intraday High Probability Setup Alerts - newser.com
Will CareDx Inc stock deliver better than expected guidance2025 Year in Review & Proven Capital Preservation Tips - newser.com
Why CareDx Inc (1K9) stock signals breakout potential2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Why CareDx Inc (1K9) stock remains stableJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - newser.com
Is CareDx Inc stock trading near support levelsJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
What is the fair value estimate for CareDx Inc (1K9) stock in 2025Trade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Can CareDx Inc (1K9) stock expand revenue streamsGap Up & Community Consensus Stock Picks - newser.com
What Fibonacci levels say about CareDx Inc reboundWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Applying sector rotation models to CareDx IncMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
Trend analysis for CareDx Inc this weekMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):